| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1200482 | Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as reduction in cytopathic effect at 100 uM after 48 hrs by plaque assay | 2015 | European journal of medicinal chemistry, Mar-26, Volume: 93 | Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin. |
| AID1818937 | Cytotoxicity against African green monkey Vero E6 cells expressing TMPRSS2 assessed as reduction in cell viability incubated for 24 hrs by DAPI staining based confocal microscopic analysis | 2022 | Journal of natural products, 01-28, Volume: 85, Issue:1
| Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives. |
| AID1818932 | Antiviral activity against HCV JFH-1 infected in human Huh-7.5.1 cells assessed as reduction in viral replication measured after 72 hrs by chemiluminescent enzyme immunoassay | 2022 | Journal of natural products, 01-28, Volume: 85, Issue:1
| Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives. |
| AID311562 | DPPH radical scavenging activity | 2007 | Journal of natural products, Oct, Volume: 70, Issue:10
| Isoechinulin-type alkaloids, variecolorins A-L, from halotolerant Aspergillus variecolor. |
| AID1200484 | Cytotoxicity against MDCK cells assessed as cell growth after 40 hrs by CellTiter-Glo assay | 2015 | European journal of medicinal chemistry, Mar-26, Volume: 93 | Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin. |
| AID1818936 | Antiviral activity against SARS-CoV-2 WK-251 infected in African green monkey Vero E6 cells expressing TMPRSS2 assessed as reduction in viral RNA replication incubated for 24 hrs by qRT-PCR analysis | 2022 | Journal of natural products, 01-28, Volume: 85, Issue:1
| Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives. |
| AID1818933 | Cytotoxicity against human Huh-7.5.1 cells assessed as reduction in cell viability measured at 72 hrs by MTT assay | 2022 | Journal of natural products, 01-28, Volume: 85, Issue:1
| Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |